-
NHS-Biotin Workflows for Protein Labeling
2026-09-01
NHS-Biotin converts accessible lysines and N-terminal amines into stable biotin tags for streptavidin-based detection, purification, and cell-labeling workflows. Its short spacer and membrane permeability also make it useful when engineered nanobody assemblies require low-profile, versatile assay readouts.
-
ALDOB K87 Lactylation in Pulmonary Hypertension
2026-08-31
A 2026 Communications Biology study identifies ALDOB K87 lactylation as a mechanistic link between hypoxia-driven glycolysis, lactate accumulation, DRP1-dependent mitochondrial fission, and pulmonary artery smooth muscle cell remodeling. Its integrated lactylomic, cellular, and animal-model approach positions the lactate–ALDOB–DRP1 axis as a potential framework for studying metabolic control of pulmonary hypertension.
-
HotStart qPCR Master Mix for Fruit Abscission
2026-08-30
Use HotStart Universal 2X FAST Green qPCR Master Mix to convert transcriptomic candidates into rapid, quality-controlled expression assays for fruit-abscission research. Its hot-start specificity, inhibitor tolerance, Green I detection, and fixed ROX reference simplify comparisons across plant tissues and qPCR platforms.
-
Docosahexaenoic Acid (DHA) in Cell Assays
2026-08-29
A scenario-based guide to using Docosahexaenoic Acid (DHA), SKU C4188, in cell viability, proliferation, and cytotoxicity workflows. It connects product specifications with recent hippocampal lipid-metabolism evidence and provides practical guidance for solvent selection, controls, interpretation, and vendor comparison.
-
Merbromin as a Mixed-Type SARS-CoV-2 3CLpro Inhibitor
2026-08-29
The reference study used an enzyme-activity high-throughput screen of approximately 6,000 compounds to identify merbromin as a selective inhibitor of SARS-CoV-2 3CLpro. Kinetic, binding, and docking analyses supported mixed-type inhibition and suggested more than one interaction site, providing a mechanistic starting point for antiviral inhibitor design rather than clinical validation.
-
AptaBLE: Deep Learning for Aptamer Design
2026-08-28
AptaBLE is a preprint describing a sequence-based deep learning platform that combines pretrained protein and nucleic acid encoders with symmetric bidirectional cross-attention to predict aptamer–protein binding. The framework also supports de novo aptamer generation, offering a computational route for prioritizing candidates before experimental validation while highlighting unresolved questions about generalization, data quality, and wet-lab transferability.
-
ACE2, MasR–Sirt1, and Sepsis Cardiomyopathy
2026-08-28
A February 2024 study identifies ACE2 downregulation as a mechanistic feature of sepsis-induced cardiomyopathy and links ACE2 activation to MasR–Sirt1-mediated mitochondrial biogenesis. Using pharmacological activation and inhibition in a mouse cecal ligation and puncture model, the work connects improved cardiac function with reduced inflammation, oxidative stress, and apoptosis.
-
Olsalazine Sodium: From Chemotaxis to Translation
2026-08-27
Olsalazine Sodium is more than an anti-inflammatory reagent: it offers a mechanistically interesting bridge between LTB4-driven immune behavior, tumor biology, and xenobiotic transport. This thought-leadership article explains how translational researchers can use the mesalamine dimer to design better colorectal cancer studies while avoiding overinterpretation of cross-domain evidence.
-
Sodium Citrate in Reproducible SERS Design
2026-08-27
Sodium citrate can influence pH, metal-ion availability, and colloid behavior in SERS workflows, but its role must be separated from nanostructure geometry. This article connects citrate chemistry with the polymer pen lithography evidence to improve experimental controls and assay decisions.
-
Quercetin Glycoside LNPs Reduce mRNA Inflammation
2026-08-26
The reference study introduces quercetin-glucoside derivatives as modular lipid nanoparticle components that improve in vivo mRNA delivery while reducing inflammatory responses. Its lead formulation, based on quercetin-di-glucoside at 30 molar substitution, increased lymph node transfection and adaptive immune responses without sacrificing particle stability or biocompatibility.
-
Bacitracin B1670: Practical Research Guide
2026-08-26
Bacitracin B1670 supports controlled antibacterial research where reproducible preparation, vehicle matching, and assay controls are needed to study bacterial cell wall and peptidoglycan synthesis disruption. It is intended for scientific research workflows only and should not be used for diagnostic, clinical, or medical applications.
-
Tacalcitol Monohydrate: A VDR Assay Guide
2026-08-25
Tacalcitol monohydrate is a synthetic analog of vitamin D3 for mechanism-driven dermatology, NGF, and colorectal cancer research. This guide connects VDR/CaSR biology with assay design, concentration selection, and evaluation of 5-fluorouracil sensitization.
-
Temozolomide Workflows for ATRX-Aware Glioma Research
2026-08-25
Temozolomide offers a controllable way to model DNA alkylation, cytotoxicity, and treatment response in glioma and other cancer systems. This guide combines DMSO handling, ATRX-stratified assay design, combination testing, and practical troubleshooting for more reproducible DNA repair mechanism research.
-
Go 6983 Workflows for PKC Signaling and EMT
2026-08-24
Go 6983 enables controlled inhibition of several PKC isoforms in cancer progression studies, epithelial-to-mesenchymal transition assays, and mechanistic signaling experiments. This workflow-focused guide connects dose design, metabolic readouts, and blastoid research while clearly separating established evidence from hypothesis-generating applications.
-
ACE2, Diminazene Aceturate, and Septic Cardiomyopathy
2026-08-23
The February 2024 study identifies a mechanistic link between ACE2 activation, MasR-Sirt1 signaling, and mitochondrial biogenesis in sepsis-induced cardiomyopathy. Using complementary pharmacological activation and inhibition in a mouse cecal ligation and puncture model, the authors connect mitochondrial preservation with improved cardiac function, lower inflammation, reduced oxidative stress, and less cardiomyocyte apoptosis.
449 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page